The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, R. E.
Right arrow Articles by Mowat, A. McI.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, R. E.
Right arrow Articles by Mowat, A. McI.
The Journal of Immunology, 1999, 162: 5536-5546.
Copyright © 1999 by The American Association of Immunologists

Immune-Stimulating Complexes Induce an IL-12-Dependent Cascade of Innate Immune Responses1

Rosemary E. Smith*, Anne M. Donachie*, Dubravka Grdic{dagger}, Nils Lycke{dagger} and Allan McI. Mowat*

* Department of Immunology, University of Glasgow, Western Infirmary, Glasgow, United Kingdom; and {dagger} Department of Microbiology and Immunology, University of Gothenburg, Gothenburg, Sweden

The development of subunit vaccines requires the use of adjuvants that act by stimulating components of the innate immune response. Immune-stimulating complexes (ISCOMS) containing the saponin adjuvant Quil A are potential vaccine vectors that induce a wide range of Ag-specific responses in vivo encompassing both humoral and CD4 and CD8 cell-mediated immune responses. ISCOMS are active by both parenteral and mucosal routes, but the basis for their adjuvant properties is unknown. Here we have investigated the ability of ISCOMS to recruit and activate innate immune responses as measured in peritoneal exudate cells. The i.p. injection of ISCOMS induced intense local inflammation, with early recruitment of neutrophils and mast cells followed by macrophages, dendritic cells, and lymphocytes. Many of the recruited cells had phenotypic evidence of activation and secreted a number of inflammatory mediators, including nitric oxide, reactive oxygen intermediates, IL-1, IL-6, IL-12, and IFN-{gamma}. Of the factors that we investigated further only IL-12 appeared to be essential for the immunogenicity of ISCOMS, as IL-6- and inducible nitric oxide synthase knockout (KO) mice developed normal immune responses to OVA in ISCOMS, whereas these responses were markedly reduced in IL-12KO mice. The recruitment of peritoneal exudate cells following an injection of ISCOMS was impaired in IL-12KO mice, indicating a role for IL-12 in establishing the proinflammatory cascade. Thus, ISCOMS prime Ag-specific immune responses at least in part by activating IL-12-dependent aspects of the innate immune system.




This article has been cited by other articles:


Home page
 Infect. Immun.Home page
L. Barfod, M. A. Nielsen, L. Turner, M. Dahlback, A. T. R. Jensen, L. Hviid, T. G. Theander, and A. Salanti
Baculovirus-Expressed Constructs Induce Immunoglobulin G That Recognizes VAR2CSA on Plasmodium falciparum- Infected Erythrocytes
Infect. Immun., July 1, 2006; 74(7): 4357 - 4360.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Spadaro, E. Ambrosino, M. Iezzi, E. Di Carlo, P. Sacchetti, C. Curcio, A. Amici, W.-Z. Wei, P. Musiani, P.-L. Lollini, et al.
Cure of Mammary Carcinomas in Her-2 Transgenic Mice through Sequential Stimulation of Innate (Neoadjuvant Interleukin-12) and Adaptive (DNA Vaccine Electroporation) Immunity
Clin. Cancer Res., March 1, 2005; 11(5): 1941 - 1952.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
H. Beacock-Sharp, A. M. Donachie, N. C. Robson, and A. M. Mowat
A role for dendritic cells in the priming of antigen-specific CD4+ and CD8+ T lymphocytes by immune-stimulating complexes in vivo
Int. Immunol., June 1, 2003; 15(6): 711 - 720.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Chen, K.-F. Hu, B. Rozell, C. Orvell, B. Morein, and P. Liljestrom
Vaccination with Recombinant Alphavirus or Immune-Stimulating Complex Antigen Against Respiratory Syncytial Virus
J. Immunol., September 15, 2002; 169(6): 3208 - 3216.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. M. I. Mowat, A. M. Donachie, S. Jagewall, K. Schon, B. Lowenadler, K. Dalsgaard, P. Kaastrup, and N. Lycke
CTA1-DD-Immune Stimulating Complexes: a Novel, Rationally Designed Combined Mucosal Vaccine Adjuvant Effective with Nanogram Doses of Antigen
J. Immunol., September 15, 2001; 167(6): 3398 - 3405.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Krishnan, S. Sad, G. B. Patel, and G. D. Sprott
The Potent Adjuvant Activity of Archaeosomes Correlates to the Recruitment and Activation of Macrophages and Dendritic Cells In Vivo
J. Immunol., February 1, 2001; 166(3): 1885 - 1893.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. P. Simmons, P. Mastroeni, R. Fowler, M. Ghaem-maghami, N. Lycke, M. Pizza, R. Rappuoli, and G. Dougan
MHC Class I-Restricted Cytotoxic Lymphocyte Responses Induced by Enterotoxin-Based Mucosal Adjuvants
J. Immunol., December 15, 1999; 163(12): 6502 - 6510.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.